Effect of Vajigandhadi taila pana and Basti in Gridhrasi (Sciatica)

A comperative efficacy of Vajigandhadi taila pana and Basti in the management of Gridhrasi (Sciatica) - A randomized clinical trial

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/04/006798

Enrollment

Registered

2016-04-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Group-A Vajigandhadi Taila Pana(VGP):-In this group classical Vajigandhadi Taila Pana will be administered: In this group, Vajigandhadi Taila Pana(ashwgandha,bala, bilva,dashmool,erand

Eligibility

Inclusion criteria

Inclusion criteria: •Diagnosed cases of gridhrasi(sciatica). •Positive SLR test. •Patients between the age group 18-70 years of either sex. •Patients with madhyama andkroorakostha.

Exclusion criteria

Exclusion criteria: •Mrudukostha. •Patients age group 70years will be excluded. •Fracture of vertebrae. •Known case of T.B or Neoplasm of spine & hip joint. •Deformities and congenital defects of spine and hipjoint. •Uncontrolled hypertension and diabetes. •Heart disease & any other serious systemic illness. •Pregnancy •Patients contraindicated for Snehapana and Basti.

Design outcomes

Primary

Measure	Time frame
It is expected that the trial drugs will exert a significant action over sciaticaTimepoint: 4 weeks	—

Secondary

Measure	Time frame
It is expected that the trial drugs will exert a significant action over sciaticaTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactP K Prajapati

IPGT and RA

prajapati.pradeep1@gmail.com9428315733

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026